Safety and Tolerability Study of N6022 in Healthy Subjects
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
The purpose of this study is to evaluate the safety and tolerability of N6022 in healthy subjects.
Key facts
- Study ID
- NCT01147406
- Run by
- Nivalis Therapeutics, Inc.
- People needed
- 41
- Starts
- 2010-08-01
- Expected to finish
- 2011-06-01
- Last updated by the study team
- 2014-03-07
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.
Where it is running
- Parexel Early Phase Unit — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.